The role of cyclooxygenase-2 in breast cancer: review Gurpreet Singh-RangerMohamed SalhabKefah Mokbel Review 12 July 2007 Pages: 189 - 198
Spindle cell lesions of the breast—the pathologic differential diagnosis Gary M. K. TsePuay Hoon TanThomas C. Putti Review 18 July 2007 Pages: 199 - 207
HER2/neu in systemic therapy for women with breast cancer: a systematic review Bindi Dhesy-ThindKathleen I. PritchardMaureen Trudeau Review 17 July 2007 Pages: 209 - 229
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials Emilio BriaFederica CupponeDiana Giannarelli Review 19 July 2007 Pages: 231 - 239
Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells Leslie Hodges-GallagherCathleen D. ValentinePeter J. Kushner Preclinical Study 19 July 2007 Pages: 241 - 250
Core wash cytology of breast lesions by ultrasonographically guided core needle biopsy Takayoshi UematsuMasako Kasami Preclinical Study 07 July 2007 Pages: 251 - 253
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer Looket DihgePär-Ola BendahlMårten Fernö Preclinical Study 17 July 2007 Pages: 255 - 262
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone Michael J. WillhauckBibi Sharif-SamaniChristine Spitzweg Preclinical Study 18 July 2007 Pages: 263 - 272
1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways Kathy VanderlaagYunpeng SuStephen Safe Preclinical Study 12 July 2007 Pages: 273 - 283
Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study Robert D. KilgourDavid H. JonesJohn R. Keyserlingk Preclinical Study 11 July 2007 Pages: 285 - 295
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian “tumor of breast tissue: incidence, genetics, and environmental risk factors” study Uwe LangsenlehnerGerald WolfWilfried Renner Preclinical Study 17 July 2007 Pages: 297 - 304
Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies Carsten T. ViehlDaniel M. FreyPeter S. Goedegebuure Preclinical Study 26 July 2007 Pages: 305 - 314
A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1 Nedret AltiokHeather MezzadraSoner Altiok Preclinical Study 19 July 2007 Pages: 315 - 323
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome Somaia ElsheikhAndrew R. GreenIan O. Ellis Preclinical Study 26 July 2007 Pages: 325 - 335
Assessment of clinical response after two cycles of primary chemotherapy in breast cancer Mark J. BeresfordDavid StottAndreas Makris Clinical Trial 11 July 2007 Pages: 337 - 342
A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study Philippe A. CassierSylvie ChabaudThomas Bachelot Clinical Trial 05 July 2007 Pages: 343 - 350
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information Lisa RydénGöran LandbergPär-Ola Bendahl Clinical Trial 18 July 2007 Pages: 351 - 357
Prevalence and prognostic and predictive relevance of PRAME in breast cancer Padraig DoolanMartin ClynesLorraine O’Driscoll Epidemiology 12 July 2007 Pages: 359 - 365
Assessing the economic burden of breast cancer in a US managed care population John J. BarronRalph QuimboMayur M. Amonkar Epidemiology 03 August 2007 Pages: 367 - 377
Health-related quality of life before and after a breast cancer diagnosis Amy Trentham-DietzBrian L. SpragueJohn M. Hampton Epidemiology 03 August 2007 Pages: 379 - 387
The impact of diabetes on survival following breast cancer Lorraine L. LipscombePamela J. GoodwinJanet E. Hux Epidemiology 21 July 2007 Pages: 389 - 395
Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study George C. ZografosFlora ZagouriJohn Bramis Epidemiology 26 July 2007 Pages: 397 - 402
Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer Omer DizdarNilufer BulutKadri Altundag Letter to the Editor 11 July 2007 Pages: 403 - 403
